Gene Therapies. New Payment Models. FDA Approval Standards.

 

CONFIRMED SPEAKERS

JOE GROGAN (WHITE HOUSE)

SCOTT GOTTLIEB (AEI)

JANET WOODCOCK (FDA)

GIDEON BLUMENTHAL (FDA) 

PETER MARKS (FDA)

BOB TEMPLE (FDA)

WILSON BRYAN (FDA)

HYLTON JOFFE (FDA)

TIFFANY FARCHIONE (FDA)

AMY HALL (HOUSE WAYS & MEANS) 

LARA STRAWBRIDGE (CMS)

CO-PRODUCED BY PREVISION POLICY + FRIENDS OF CANCER RESEARCH

 

LEAD 2019 BIOPHARMA CONGRESS SPONSOR

 

2019 INDUSTRY SPONSORS

 
 
 
 
 
 
 

agenda

view our agenda of regulators, policy makers, and drug developers

Learn More →

Register

space is limited. register now.

Find Out How →